138 related articles for article (PubMed ID: 3895826)
1. Urinary excretion of kallikrein before and after operation for aldosterone-producing adenoma.
Hesse B; Rasmussen S; Lund JO; Christensen P; Damkjaer Nielsen M
Acta Med Scand; 1985; 217(5):501-5. PubMed ID: 3895826
[TBL] [Abstract][Full Text] [Related]
2. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
Nakada T
Urol Int; 1984; 39(1):40-5. PubMed ID: 6375065
[TBL] [Abstract][Full Text] [Related]
3. Direct and indirect measurement of urinary kallikrein excretion in patients with essential hypertension and normotensives: relation to age and plasma renin and aldosterone levels.
Koolen MI; Daha MR; Frölich M; Van Es LA; Van Brummelen P
Eur J Clin Invest; 1984 Jun; 14(3):171-4. PubMed ID: 6432545
[TBL] [Abstract][Full Text] [Related]
4. Effect of spironolactone on urinary kallikrein excretion in patients with essential hypertension and in primary aldosteronism.
Seino M; Abe K; Sakurai Y; Irokawa N; Yasujima M; Chiba S; Otsuka Y; Yoshinaga K
Tohoku J Exp Med; 1977 Feb; 121(2):111-9. PubMed ID: 847738
[TBL] [Abstract][Full Text] [Related]
5. Urinary kallikrein excretion in essential and mineralocorticoid hypertension.
Holland OB; Chud JM; Braunstein H
J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684
[TBL] [Abstract][Full Text] [Related]
6. 21-Deoxytetrahydroaldosterone excretion in primary hyperaldosteronism.
Abdelhamid S; Lewicka S; Vecsei P; Winter J
Cardiology; 1985; 72 Suppl 1():102-6. PubMed ID: 4053120
[TBL] [Abstract][Full Text] [Related]
7. Fludrocortisone suppression test in normal subjects, in patients with essential hypertension and in patients with various forms of aldosteronism.
Lund JO; Nielsen MD
Acta Endocrinol (Copenh); 1980 Jan; 93(1):100-7. PubMed ID: 6986736
[TBL] [Abstract][Full Text] [Related]
8. [Urinary kallikrein and other vasoactive substances in patients with primary aldosteronism and essential hypertension].
Nakada T
Nihon Hinyokika Gakkai Zasshi; 1983 Jun; 74(6):977-88. PubMed ID: 6361347
[No Abstract] [Full Text] [Related]
9. Abnormal urinary kallikrein in hypertension is not related to aldosterone or plasma renin activity.
Lawton WJ; Fitz AE
Hypertension; 1980; 2(6):787-93. PubMed ID: 7007236
[TBL] [Abstract][Full Text] [Related]
10. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
[TBL] [Abstract][Full Text] [Related]
11. Urinary kallikrein excretion and sodium metabolism in hypertensive patients.
Seino M; Abe K; Otsuka Y; Saito T; Irokawa N
Tohoku J Exp Med; 1975 Aug; 116(4):359-367. PubMed ID: 1188919
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism.
Takeda Y; Miyamori I; Iki K; Takeda R; Vecsei P
Acta Endocrinol (Copenh); 1992 Jun; 126(6):484-8. PubMed ID: 1642080
[TBL] [Abstract][Full Text] [Related]
13. Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism.
Lechi A; Covi G; Lechi C; Corgnati A; Arosio E; Zatti M; Scuro LA
Clin Sci Mol Med; 1978 Jul; 55(1):51-5. PubMed ID: 668267
[TBL] [Abstract][Full Text] [Related]
14. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
Clin Exp Hypertens (1978); 1980; 2(3-4):693-708. PubMed ID: 7000466
[TBL] [Abstract][Full Text] [Related]
15. Dissociation in the excretion of different aldosterone metabolites and unmetabolized ('free') aldosterone in hypertension.
Abdelhamid S; Vecsei P; Haack D; Gless KH; Walb D; Lichtwald K; Fiegel P
Clin Sci (Lond); 1979 Nov; 57(5):409-14. PubMed ID: 519948
[TBL] [Abstract][Full Text] [Related]
16. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
Marzecka J
Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
[TBL] [Abstract][Full Text] [Related]
17. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
[TBL] [Abstract][Full Text] [Related]
18. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():247s-250s. PubMed ID: 396074
[TBL] [Abstract][Full Text] [Related]
19. Urinary kallikrein excretion in Bartter's syndrome.
Lechi A; Covi G; Lechi C; Mantero F; Scuro LA
J Clin Endocrinol Metab; 1976 Nov; 43(5):1175-8. PubMed ID: 993321
[TBL] [Abstract][Full Text] [Related]
20. Urinary kallikrein in normal renin essential hypertension.
Lawton WJ; Fitz AE
Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
